CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- 8-K Event Material agreement
- S-1/A Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
- 424B3 Offering Prospectus
- 8-K Event Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
Page 11 of 21 · 406 filings